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ABSTRACT
Background    Recently, a lot of cases with microcal-
cifications of the breast are pointed by the images of 
mammography (MG), because breast screening using 
MG become common. Although MG is a gold standard 
modality for detecting microcalcifications, images of 
ultrasonography (US) are now feasible to detect micro-
calcifications with recent improvements to ultrasound 
diagnostic devices. In this report, we analyzed clinical 
significance of microcalcifications detected with US im-
ages in invasive breast carcinoma.
Methods    Eighty-eight patients with invasive breast 
carcinoma who underwent MG and US before surgery at 
the Division of Breast and Endocrine Surgery of Tottori 
University Hospital between January 2012 and Au-
gust 2013. After reviewing US images, the association 
between the presence of echogenic spots that indicate 
microcalcifications and images of MG or pathological 
findings was assessed.
Results    Patients without microcalcifications on US 
images were significantly more likely to have the Lumi-
nal A subtype and a lower nuclear grading. Conversely, 
patients with microcalcifications on US images were 
significantly more likely to have higher level of MIB-
1 index, lymphovascular invasion, comedonecrosis and 
lymph node metastasis. The rate of detecting microcalci-
fications on US images was relatively good, with 81.8% 
of sensitivity, 94.5% of specificity and 89.8% of diagnos-
tic accuracy. Among the calcifications detected by MG 
images, detected rate of calcifications with US images 
was higher in necrotic type (92.6%) than secretory type 
(33.3%).
Conclusion    This study suggest that microcalcifica-
tions of tumors detected by US images could serve as an 
useful prediction to evaluate the degree of malignancy 
for patients with invasive breast carcinoma.
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Recently, a lot of cases with microcalcifications of the 
breast are pointed by the images of mammography (MG), 
because breast screening using MG become common. 
Although MG is a gold standard modality for detecting 
microcalcifications, images of ultrasonography (US) are 
now feasible to detect microcalcifications with recent 
improvements to ultrasound diagnostic devices.1-4 There 
have been several studies on the performance of US for 
detecting microcalcifications, but most reports focused 
on ductal carcinoma in situ (DCIS).1–3, 5 Microcalcifica-
tions are seen in invasive carcinomas as well as DCIS 
(Fig. 1), but there have been few detailed studies about 
the significance of microcalcifications in such carcino-
mas. In this study, we compared the presence of micro-
calcifications on US images with findings from MG im-
ages and clinical pathology, to interpret the significance 
of detection of microcalcifications on US images.
SUBJECTS AND METHODS
Patients
Eighty-eight patients with invasive breast carcinoma 
who underwent preoperative MG and US in the Division 
of Breast and Endocrine Surgery of Tottori University 
Hospital between January 2012 and August 2013 were 
retrospectively investigated. Patients with DCIS and 
those who received neoadjuvant chemotherapy were ex-
cluded.  
Methods
US examinations were performed using a HI VISION 
Preirus (Hitachi Aloka Medical, Tokyo, Japan) with an 
EUP-L74M probe (linear, center frequency: 7.5 MHz). 
Echogenic spots indicative of microcalcifications were 
defined as discontinuous echogenic spots within a mass 
or hypoechoic area, or clustered echogenic spots clearly 
different from the mammary glands (Fig. 2). In this 
study, we defined microcalcifications detected by MG 
images as positive cases of microcalcifications. Preoper-
ative MG and US images were retrospectively reviewed 
individually without patients information by a medical 
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breast cancer specialist who had over 25 years experi-
ences in breast examinations and a medical sonographer 
(superficial organs) with over 3 years experiences. When 
mutual evaluation of findings was not matched, consen-
suses were got in each other. The association between 
the presence of echogenic spots within a tumor on US 
images and findings from MG images and pathological 
features of the resected specimen (subtype, histologic 
type, lymphovascular invasion, comedonecrosis, nuclear 
grading, MIB-1 index and lymph node metastases) were 
investigated. Fischer’s exact test and the Mann-Whitney 
U test were used for statistical analysis. P values of less 
than 0.05 were considered to indicate statistically sig-
nificant differences. This study was conducted with the 
approval of the Ethics Committee of Tottori University 
Faculty of Medicine. 
Fig. 1. US images show microcalcifications (arrows) observed not only in DCIS (left) but also in inva-
sive carcinoma (right). DCIS, ductal carcinoma in situ; US, ultrasonography.
RESULTS
All patients were female and mean age was 61.2 years 
(range: 28–87 years). Table 1 shows the results of re-
lationship between US and MG images for detecting 
microcalcifications in all 88 patients. Microcalcifications 
were detected in 33 patients but not in 55 patients with 
MG images. Twenty-seven of the 33 patients appeared as 
echogenic spots on US images. US examination showed 
81.8% sensitivity, 94.5% specificity and 89.8% diagnos-
tic accuracy for detecting microcalcifications. There 
were 6 false negatives where microcalcifications were 
detected with MG but not US images. Conversely, there 
were 3 false positives where microcalcifications were 
not detected with MG but echogenic spots were seen 
on US images. In such false positive cases, pathological 
specimens revealed no microcalcifications and no char-
acteristic features.
Fig. 1
Fig. 2-A
Fig. 2-B
A
B
Fig. 2. Microcalcifications on US images.
A: Transverse (left) and longitudinal (right) US 
images of the AC area of the left breast. Noncon-
tinuous echogenic spots (arrows) were observed 
on orthogonal tomographic images.
B: Longitudinal image of the C area of the left 
breast. Punctuate echogenic spots (arrows) with a 
tissue composition clearly different from that of 
the mammary glands were observed inside the 
mass.
US, ultrasonography.
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Table 1. Detection of microcalcifications with MG and 
US
MG Total+ −
US
+ 27 3 30
− 6 52 58
Total 33 55 88
US examination showed 81.8% sensitivity, 94.5% specificity and 
89.8% diagnostic accuracy for detecting microcalcifications.
MG, mammography; US, ultrasonography.
showed 92.6% sensitivity, 66.7% specificity for detecting 
necrotic calcifications. In six false negative cases, 4 had 
secretary types and 2 had necrotic types.
 Table 3 shows a correlation between the presence of 
microcalcifications and clinicopathological findings in 
79 patients, with the 3 false positives and 6 false nega-
tives excluded. Patients without microcalcifications were 
significantly more likely to have the Luminal A subtype 
(P < 0.01) and a lower nuclear grading (P < 0.05). Con-
versely, patients with microcalcifications were signifi-
cantly more likely to have lymphatic invasion (P < 0.05), 
comedonecrosis (P < 0.01), more lymph node metastases 
(P < 0.01) and higher level of MIB-1 index (34.8% vs. 
22.0%; P < 0.01) (Fig. 3). Histologic type and vascular 
invasion were not associated with the presence of micro-
calcifications.
Table 2. US detectivity for microcalcifications
Type of microcaplcification with MG P value
Necrotic (pleomorphic or linear/branching) Secretory (amorphous)
US
+ 25 2
< 0.01
− 2 4
US examination showed 92.6% sensitivity, 66.7% specificity for detecting necrotic calcifications.
MG, mammography; US, ultrasonography.
Table 3. Microcalcifications and pathological findings
Microcalcification
P value+ −
(n = 27) (n = 52)
Subtype
Luminal A 0 17
< 0.01
Luminal B(HER2−) 19 25
Luminal B(HER2+) 3 2
HER2 enriched 2 3
Triple negative 3 5
Histological classification
Scirrhous carcinoma 8 20
NS
Solid-tubular carcinoma 7 8
Papillotubular carcinoma 11 14
Special types 1 10
Lymphatic invasion 
+ 16 15 < 0.05
− 11 36
Vascular invasion 
+ 2 1 NS
− 25 50
Comedonecrosis
+ 21 17 < 0.01
− 5 33
Nuclear atypia
1 1 11
< 0.052 20 20
3 5 11
Number of mitotic counts
1 3 19
< 0.052 13 16
3 10 7
Nuclear grading
1 3 19
< 0.052 11 10
3 12 13
Lymph node metastases 
+ 14 8 < 0.01
− 13 44
HER2, human epidermal growth factor receptor 2; NS, not significant.
 US detectivity for microcalcifications was evaluated 
(Table 2). It was found that US examination detected a 
higher rate of pleomorphic or linear/branching calcifica-
tions that appeared to be necrotic calcifications (25/27) 
compared with amorphous calcifications that appeared 
to be secretory calcifications (2/6). And US examination 
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receptor 2 (HER2) is associated with microcalcifica-
tions, but there is no association in our study. The reason 
for this may be the different rate of patients with HER2 
overexpression. Seo et al.13 reported approximately 30% 
of all patients with HER2 overexpression, whereas our 
study included a small number of patients (13%).
 In contrast, patients with microcalcifications on US 
images were significantly more likely to have lymphatic 
invasion, comedonecrosis, more lymph node metastases 
and higher level of MIB-1 index. Previous studies have 
shown that lymphovascular invasion,14 comedonecrosis15 
and MIB-1 index16 could be useful prognostic factors of 
the patients with breast carcinoma. Additionally, axillary 
lymph node metastasis is a major prognostic factor and 
play an important role in selecting adjuvant therapy.17–19 
As described above, lymphatic invasion, comedonecro-
sis, lymph node metastases and higher level of MIB-1 
index are considered indicators of high grade malig-
nancy and poor prognosis. These findings suggest that 
breast carcinoma with microcalcifications may be high 
grade malignant and the patients with them have an un-
favorable prognosis.
 The results of US images for detecting microcal-
cifications in this study were inferior to those of MG 
images, but still relatively good of sensitivity, specificity 
and diagnostic accuracy. Calcifications of the breast can 
be conceptually divided into three major types: stro-
mal, secretory and necrotic. The stromal type develops 
through hyalinization of the stroma and appears on MG 
images as coarse calcifications. Secretory calcifications 
develop through crystallization of secretions and are 
seen in benign mastopathy as well as low grade breast 
carcinoma. On MG images, they appear as small round 
or amorphous calcifications. Necrotic calcifications are 
caused by comedonecrosis. Studies have shown that in 
the tumor of breast carcinoma, necrosis occurs as a re-
sult of poor blood flow caused by rapid growth and cal-
cium deposits form in those areas.20–22 On MG images, 
necrotic type appear as pleomorphic or linear/branching 
calcifications. The stromal type of calcifications is diag-
nosed as benign, the necrotic type as malignant, and the 
secretory type are seen in a variety lesions of both be-
nign and malignant conditions. Among the calcifications 
detected by MG images, detected rate of calcifications 
with US images was higher in necrotic type than secre-
tory type. And US examination showed 92.6% sensitiv-
ity for detecting necrotic calcifications. Secretary type 
calcifications are smaller and paler than necrotic type, 
therefore, it could be closed in the surrounding mam-
mary gland composition, and it seemed to be false nega-
tive on US images. These findings indicate that necrotic 
calcifications could be detected easier with US images 
in invasive carcinoma. 
DISCUSSION
In this study, there were some cases without confirma-
tion of microcalcifications on pathological specimens, 
though microcalcifications were found clearly on MG 
images. Sensitivity and specificity to detect microcalcifi-
cations on MG images were good with 89.7% and 90.7% 
respectively.6 Therefore, we defined microcalcifications 
detected by MG images as positive cases of microcalci-
fications. 
 Most studies conducted on the performance of 
US for detecting microcalcifications have focused on 
DCIS.1–3, 5 Nagashima et al.1 found that the detection 
rate of microcalcifications with US images was higher 
for comedo type of DCIS than non comedo type. How-
ever, there have been few studies on the significance of 
microcalcifications in invasive carcinoma. In this study, 
we compared the presence of microcalcifications on US 
images to findings of MG images and clinical pathology, 
to interpret the significance of detection of microcalcifi-
cations on US images.
 In our study, patients without microcalcifications 
on US images were significantly more likely to have the 
Luminal A subtype and a lower nuclear grading. Many 
previous studies have shown that the patients with Lumi-
nal A subtype have a good outcome compared with the 
other subtypes due to high hormone sensitivity and low 
expression of proliferative genes.7–10 The nuclear grad-
ing of invasive ductal carcinoma has also been shown to 
be useful as an indicator of degree of malignancy and as 
a clinical prognostic factor, with higher nuclear grading 
having a less favorable prognosis.11, 12 Seo et al.13 found 
that overexpression of human epidermal growth factor 
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Microcalcification Microcalcification
0 
20 
40 
60 
80 
100 
(%)
**
??????????????????????????????????????????????????
??????????????????????????????????????????????????
?????????????????????????????????????????????????
Fig. 3. The average value of MIB-1 index was 34.8% for the pa-
tients with microcalcifications (n = 27), whereas 22.0% for those 
without microcalcifications (n = 52). **P < 0.01.
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 In conclusion, this study suggest that the detection 
ability of microcalcifications on US was inferior to MG, 
but microcalcifications of tumors detected by US images 
could easily serve as an useful prediction to evaluate the 
degree of malignancy, furthermore, it may be possible to 
decide the selection of adjuvant chemotherapy. In addi-
tion, US examination can check it repeatedly without a 
radiation exposure, and may be useful method to detect 
the tumor for the patients with dense breast.23 We con-
sidered that preoperative US is useful diagnostic tool for 
the patients with breast disease. 
 
The authors declare no conflict of interest.
REFERENCES
1 Nagashima T, Hashimoto H, Oshida K, Nakano S, Tanabe N, 
Nikaido T, et al. Ultrasound Demonstration of Mammograph-
ically Detected Microcalcifications in Patients with Ductal 
Carcinoma in situ of the Breast. Breast Cancer. 2005;12:216-
20. PMID: 16110292.
2 Moon WK, Im JG, Koh YH, Noh DY, Park IA. US of mam-
mographically detected clustered microcalcifications. Radiol-
ogy. 2000;217:849-54. PMID: 11110953.
3 Soo MS, Baker JA, Rosen EL. Sonographic detection and 
sonographically guided biopsy of breast microcalcifications. 
AJR Am J Roentgenol. 2003;180:941-8. PMID: 12646433.
4 Kamiyama N, Okamura Y, Kakee A, Hashimoto H. Investiga-
tion of ultrasound image processing to improve perceptibility 
of microcalcifications. J Med Ultrasonics. 2008;35:97-105.
5 Gufler H, Buitrago-TĚllez CH, Madjar H, Allmann KH, 
Uhl M, Rohr-Reyes A. Ultrasound demonstration of mam-
mographically detected microcalcifications. Acta Radiol. 
2000;41:217-21. PMID: 10866074.
6 Okazaki H, Tsujimoto F, Maeda I, Ohta T, Kanemaki
 Y, Okamoto K, et al. Radiologic-pathological correlation of 
punctate hyperechoic foci by ultrasound in stereotactic vacu-
um-assisted breast biopsy samples. Jpn J Radiol. 2009;27:438-
43. PMID: 20035416.
7 Loi S. Molecular analysis of hormone receptor positive (lu-
minal) breast cancers: what have we learnt? Eur J Cancer. 
2008;44:2813-8. PMID: 18990560.
8 Buzdar AU, Ibrahim NK, Francis D, Booser DJ, Thomas ES, 
Theriault RL, et al. Significantly higher pathologic complete 
remission rate after neoadjuvant therapy with trastuzumab, pa-
clitaxel, and epirubicin chemotherapy: results of a randomized 
trial in human epidermal growth factor receptor 2-positive 
operable breast cancer. J Clin Oncol. 2005;23:3676-85. PMID: 
15738535.
9 Goldhirsch A, Wood WC, Coates AS, Gelber RD,
 Thürlimann B, Senn HJ, et al. Strategies for subtypes--dealing 
with the diversity of breast cancer: highlights of the St. Gal-
len International Expert Consensus on the Primary Therapy 
of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736-47. 
PMID: 21709140.
10 Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, 
Haibe-Kains B, et al. Meta-analysis of gene expression pro-
files in breast cancer: toward a unified understanding of breast 
cancer subtyping and prognosis signatures. Breast Cancer 
Res. 2008;10:R65. PMID: 18662380.
11 Tsuda H, Hirohashi S, Shimosato Y, Hirota T, Tsugane S, 
Watanabe S, et al. Correlation between histologic grade of 
malignancy and copy number of c-erbB-2 gene in breast 
carcinoma. A retrospective analysis of 176 cases. Cancer. 
1990;65:1794-800. PMID: 2156604.
12 The Japanese Breast Cancer Society, editor. General Rules for 
Clinical and Pathological Recording of Breast Cancer. 17th 
ed. Tokyo: Kanehara-shuppan; 2012. p. 64-67. Japanese.
13 Seo BK, Pisano ED, Kuzimak CM, Koomen M, Pavic D, Lee 
Y, et al. Correlation of HER-2/neu overexpression with mam-
mography and age distribution in primary breast carcinomas. 
Acad Radiol. 2006;13:1211-8. PMID: 16979070.
14 Kato T, Kameoka S, Kimura T, Nishikawa T, Kobayashi M. 
Blood vessel invasion as a predictor of long-term survival for 
Japanese patients with breast cancer. Breast Cancer Res Treat. 
2002;73:1-12. PMID: 12083626.
15 Yagata H, Harigaya K, Suzuki M, Nagashima T, Hashimoto 
H, Ishii G, et al. Comedonecrosis is an unfavorable marker 
in node-negative invasive breast carcinoma. Pathol Int. 
2003;53:501-6. PMID: 12895228.
16 de Azambuja E, Cardoso F, de Castro G, Colozza M, Mano 
MS, Durbecq V, et al. Ki-67 as prognostic marker in early 
breast cancer: a meta-analysis of published studies involv-
ing 12,155 patients. Br J Cancer. 2007;96:1504-13. PMID: 
17453008.
17 Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary 
nodal positivity in 2282 patients with breast carcinoma. World 
J Surg. 2001;25:767-72. PMID: 11376414.
18 Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright 
RG, McGuckin MA. Occult axillary lymph node metastases 
in breast cancer do matter: results of 10-year survival analysis. 
Am J Surg Pathol. 2002;26:1286-95. PMID: 12360043.
19 Hansen NM, Grube B, Ye X, Turner RR, Brenner RJ, 
Sim MS, et al. Impact of micrometastases in the sentinel 
node of patients with invasive breast cancer. J Clin Oncol. 
2009;27:4679-84. PMID: 19720928.
20 Japan Radiological Society, Japanese Society of Radiologi-
cal Technology, editors. [Mammography guidelines]. Tokyo: 
Igaku-shoin; 2011. p. 69-74. Japanese.
21 Tse GM, Tan PH, Cheung HS, Chu WC, Lam WW. Inter-
mediate to highly suspicious calcification in breast lesions: 
a radio-pathologic correlation. Breast Cancer Res Treat. 
2008;110:1-7. PMID: 17674189.
22 Kurebayashi J, Kurosumi M, Sonoo H. A new human breast 
cancer cell line, KPL-3C, secretes parathyroid hormone-re-
lated protein and produces tumours associated with microcal-
cifications in nude mice. Br J Cancer. 1996;74:200-7. PMID: 
8688322.
23 Bae MS, Han W, Koo HR, Cho N, Chang JM, Yi A, et al. 
Characteristics of breast cancers detected by ultrasound 
screening in women with negative mammograms. Cancer Sci. 
2011;102:1862-7. PMID: 21752153.
